These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15842209)

  • 1. Cesarean section: is pretransfusion testing for red cell alloantibodies necessary?
    Larsen R; Titlestad K; Lillevang ST; Thomsen SG; Kidholm K; Georgsen J
    Acta Obstet Gynecol Scand; 2005 May; 84(5):448-55. PubMed ID: 15842209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of routine blood type and screen testing for cesarean section.
    Ransom SB; Fundaro G; Dombrowski MP
    J Reprod Med; 1999 Jul; 44(7):592-4. PubMed ID: 10442320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and risk factors predicting blood transfusion in caesarean section.
    Chua SC; Joung SJ; Aziz R
    Aust N Z J Obstet Gynaecol; 2009 Oct; 49(5):490-3. PubMed ID: 19780731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incomplete pretransfusion testing leads to surgical delays.
    McWilliams B; Yazer MH; Cramer J; Triulzi DJ; Waters JH
    Transfusion; 2012 Oct; 52(10):2139-44; quiz 2145. PubMed ID: 22348700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood ordering in obstetrics and gynecology: recommendations for the type and screen.
    Hill ST; Lavin JP
    Obstet Gynecol; 1983 Aug; 62(2):236-40. PubMed ID: 6408546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfusion rate and prevalence of unexpected red blood cell alloantibodies in women undergoing hysterectomy for benign disease.
    Thoestesen LM; Rasmussen KL; Lauszus FF; Hansen CT; Titlestad KE; Larsen R
    Acta Obstet Gynecol Scand; 2011 Jun; 90(6):636-41. PubMed ID: 21370997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for blood transfusion during c-section in a tertiary hospital in Nigeria.
    Imarengiaye CO; Ande AB
    Med Sci Monit; 2006 Jun; 12(6):CR269-72. PubMed ID: 16733486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Incidence of alloantibodies against erythrocytes detected during pretransfusion testing 1982-1986].
    Ceizelová L; Cupaníková D; Ovecka D
    Vnitr Lek; 1987 Oct; 33(10):845-8. PubMed ID: 3686836
    [No Abstract]   [Full Text] [Related]  

  • 9. An analysis of transfusion practice and the role of intraoperative red blood cell salvage during cesarean delivery.
    Fong J; Gurewitsch ED; Kang HJ; Kump L; Mack PF
    Anesth Analg; 2007 Mar; 104(3):666-72. PubMed ID: 17312227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved efficiency in providing blood to surgical patients using a novel approach to preadmission testing.
    Jefferies LC; Smith ME; Strobl FJ; Traber KB
    Am J Med Qual; 2000; 15(6):251-6. PubMed ID: 11126594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do asymptomatic patients require routine hemoglobin testing following uneventful, unplanned cesarean sections?
    Api O; Unal O; Api M; Dogance U; Balcik O; Kara O; Turan C
    Arch Gynecol Obstet; 2010 Feb; 281(2):195-9. PubMed ID: 19404659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of routine blood type and screen testing before elective laparoscopy.
    Ransom SB; McNeeley SG; Hosseini RB
    Obstet Gynecol; 1995 Sep; 86(3):346-8. PubMed ID: 7651640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Flow cytometry in pretransfusion testing--detection of red cell antigen-antibody reactions by FCM].
    Tamura M; Takahashi H; Nakayama Y; Kasai M
    Rinsho Byori; 1985 Dec; 33(12):1386-94. PubMed ID: 3831422
    [No Abstract]   [Full Text] [Related]  

  • 14. Red cell immunization in beta thalassaemia major.
    Bhatti FA; Salamat N; Nadeem A; Shabbir N
    J Coll Physicians Surg Pak; 2004 Nov; 14(11):657-60. PubMed ID: 15530273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does a Cesarean section delivery always cost more than a vaginal delivery?
    Kazandjian VA; Chaulk CP; Ogunbo S; Wicker K
    J Eval Clin Pract; 2007 Feb; 13(1):16-20. PubMed ID: 17286718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A strategy to reduce inappropriate red blood cell transfusion.
    Brandis K; Richards B; Ghent A; Weinstein S
    Med J Aust; 1994 Jun; 160(11):721-2. PubMed ID: 8202010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alloimmunizations following blood transfusions.
    Hundrić-Haspl Z; Juraković-Loncar N; Grgicević D; Balija M
    Acta Med Croatica; 1994; 48(4-5):193-7. PubMed ID: 7534524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety in transfusion practices. Red cell compatibility testing issues.
    Shulman IA
    Clin Lab Med; 1992 Dec; 12(4):685-700. PubMed ID: 1286558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood transfusion and cesarean delivery.
    Rouse DJ; MacPherson C; Landon M; Varner MW; Leveno KJ; Moawad AH; Spong CY; Caritis SN; Meis PJ; Wapner RJ; Sorokin Y; Miodovnik M; Carpenter M; Peaceman AM; O'Sullivan MJ; Sibai BM; Langer O; Thorp JM; Ramin SM; Mercer BM;
    Obstet Gynecol; 2006 Oct; 108(4):891-7. PubMed ID: 17012451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irregular antibodies: an assessment of routine prenatal screening.
    Solola A; Sibai B; Mason JM
    Obstet Gynecol; 1983 Jan; 61(1):25-30. PubMed ID: 6401853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.